QTREX Quantum Ltd. (QTEX) SEC filings document a foreign private issuer whose disclosures focus on Form 6-K current reports, registration statements, shareholder meetings, corporate articles and equity plan updates. The company’s filings show its Nasdaq symbol, Israeli base, Form 20-F reporting status and recurring use of Form 6-K to furnish press releases and material-event information.
For QTREX, the most relevant filing topics are closely tied to its AME and quantum computing infrastructure business. Recent 6-K reports have attached announcements on AME technology deployment, cryogenic quantum interconnect research, patent-pending materials work, RF performance qualification and research collaboration activity. These filings help investors trace the company’s disclosed progress in Additively Manufactured Electronics, quantum connectivity, defense-related programs and medical technology portfolio matters.
QTREX filings also include corporate governance and capital-structure records. The company has furnished shareholder meeting materials, voting results, amended and restated articles of association, registration statement information, Form F-1 clarification materials and equity incentive plan updates. These documents are important for understanding ordinary share authorization, shareholder approvals, compensation policy votes, registration obligations and securities reserved under equity plans.
Because QTREX is not described in its recent filings as a conventional domestic issuer, its core regulatory trail is built around Form 6-K event reports and Form 20-F status rather than the standard 10-Q and 10-K pattern used by many U.S. companies. Investors researching QTEX filings often focus on material agreements, shareholder voting matters, capital-structure disclosure and furnished press releases that describe the company’s AME platform and quantum infrastructure activities.
QTREX Quantum Ltd. (QTEX) announced that it regained compliance with Nasdaq’s minimum bid price requirement. Nasdaq notified the company on October 16, 2026, after determining that the ordinary shares’ closing bid price was $1.00 per share or greater for 10 consecutive business days, from October 2, 2026, through October 15, 2026.
Nasdaq stated that the matter is closed. QTREX’s ordinary shares continue to be listed and traded on The Nasdaq Capital Market under QTEX.
QTREX Quantum Ltd. director Tal Parnes purchased 6,666 ordinary shares at $1.50 per share on October 15, 2026, in the open market. He directly held 766,666 ordinary shares after the purchase. No Rule 10b5-1 plan is reported for this transaction.
QTREX Quantum Ltd. CEO Dagi Shahar Ben-Noon reported that Noonify Ltd., which is wholly owned by the CEO, purchased 14,093 ordinary shares on October 13, 2026, at $1.49 per share. The shares were purchased in the open market as part of the management share purchase plan announced June 22, 2026; no Rule 10b5-1 plan is reported. The reported direct holding after the transaction was 3,664,314 ordinary shares.
QTREX Quantum Ltd. (QTEX) said Nasdaq notified it on October 5, 2026, that its ordinary shares’ closing bid price had been below the $1.00-per-share minimum for 30 consecutive business days, from August 20 through October 1, 2026. The notice had no immediate effect on the shares’ listing or trading on The Nasdaq Capital Market. QTREX said the closing bid price was above $1.00 per share for six consecutive business days from October 2 through October 9, 2026.
Nasdaq provided QTREX 180 calendar days from the notification, until April 3, 2027, to regain compliance. If the closing bid price is at least $1.00 per share for a minimum of 10 consecutive business days during that period, Nasdaq will provide written confirmation of compliance and close the matter.
QTREX Quantum Ltd. Chief Executive Officer and director Dagi Shahar Ben-Noon bought 18,181 ordinary shares at $1.67 per share in the open market on October 9, 2026. The purchase was part of the company's management share purchase plan announced June 22, 2026; no Rule 10b5-1 plan is reported. He directly held 3,664,314 ordinary shares after the purchase.
QTREX Quantum Ltd. reported independent testing of its additively manufactured cryogenic interconnect by a leading quantum-computing company. The release reports over 100 dB of channel isolation, described as 60 dB more than leading flexible cabling on the market, at 20 millikelvin.
The testing company used its own cryogenic system, instruments, reference cables and calibration standards. QTREX says its shared-wall channels are about one-third of a millimeter apart, with close to 30 channels per centimeter of width, and that its design conducts about half the heat of an equivalent coaxial cable. QTREX and the testing company are finalizing a binding definitive agreement. QTREX expects to disclose the testing company’s full name, field of activity and the agreement within weeks, and expects additional agreements with several quantum-computing companies in the fourth quarter of 2026.
QTREX Quantum Ltd. (QTEX) Chief Executive Officer and director Dagi Shahar Ben-Noon purchased 168,894 Ordinary Shares in open-market transactions on September 28, 2026, at a weighted average price of $0.7078 per share. The shares were purchased as part of the management share purchase plan announced June 22, 2026; no Rule 10b5-1 plan is reported. Ben-Noon held 3,646,133 shares directly following the purchase.
QTREX Quantum Ltd.’s Chief Executive Officer and director, Dagi Shahar Ben-Noon, was granted 550,000 restricted share units (RSUs) on August 28, 2026, under the company’s 2019 Plan. The amendment corrected the reported amount of securities beneficially owned following the transaction to 3,477,239, from 2,477,239.
QTREX Quantum Ltd. reported first-half 2026 revenue of $1.554 million, versus $289,000 a year earlier, with a 61% gross margin. All 2026 revenue came from the AME and Quantum segment during its first 86 days under QTREX after the acquisition closed on April 6, 2026; the comparison reflects the acquired business. Net loss was $6.354 million and operating loss was $6.936 million.
Cash, cash equivalents and deposits totaled $10.7 million at June 30, 2026, while operating activities used $3.9 million. QTREX disclosed substantial doubt about its ability to continue as a going concern because of its dependence on external funding. On August 20, 2026, it sold 11,111,111 ordinary shares at $0.90 per share, generating approximately $10 million gross and approximately $9.2 million net of offering costs; those proceeds are excluded from June 30 cash.
QTREX expects additional commercial agreements and a 2027 financial outlook in the fourth quarter of 2026. It completed a joint work plan with a U.S. national laboratory and is targeting formalization during the quarter, subject to the laboratory’s review and approval.
QTREX Quantum Ltd. (QTEX) announced that one of Israel’s three largest defense companies, described as a leading global aerospace and defense organization, has begun deploying QTREX’s Additively Manufactured Electronics (AME) technology in a joint development program focused on strategic, high‑precision systems. The first AME system is already being installed at the partner’s facilities.
The collaboration includes exclusivity provisions and a potential phased commercial pathway for broader AME system rollouts, with aggregate revenue for QTREX described as being in the tens of millions of dollars, subject to negotiation and execution of definitive agreements. The program centers on adapting QTREX’s proprietary AME platform through customized R&D, advanced materials and process optimization to meet demanding aerospace and defense requirements, with initial revenue from system deployment and recurring consumables and later phases potentially involving procurement of tailored AME systems. QTREX continues to position its AME and quantum connectivity solutions alongside its medical technology portfolio.